Ra Pharmaceuticals
Pharmaceutical ManufacturingMassachusetts, United States5001-10000 Employees
On April 2, 2020, Ra Pharmaceuticals, Inc. was acquired by UCB. For more information, please visit www.linkedin.com/company/ucb-pharma.
Acquisition Strategy Ra Pharmaceuticals was acquired by UCB, presenting a potential opportunity to cross-sell products and services to Ra Pharmaceuticals' existing customer base.
Market Expansion Recent expansions in China by UCB through asset sales indicate a growing presence in the region, offering potential sales avenues for pharmaceutical products and solutions.
Innovative Initiatives UCB's involvement in developing clinical toolkits and special podcasts showcases a commitment to innovation, creating opportunities for partnerships and product collaborations.
Revenue Potential With a revenue range of $100M to 1B, UCB presents a sizable market for high-value sales engagements and strategic partnerships.
Competitive Landscape Understanding UCB's position relative to similar companies like Vertex Pharmaceuticals and Editas Medicine can aid in tailoring competitive sales strategies and differentiation.
Ra Pharmaceuticals uses 8 technology products and services including Twitter Ads, Hotjar, SAP S/4HANA, and more. Explore Ra Pharmaceuticals's tech stack below.
Ra Pharmaceuticals Email Formats | Percentage |
FLast@rapharma.com | 86% |
Last_First@rapharma.com | 2% |
F_Last@rapharma.com | 2% |
FirstLast@rapharma.com | 2% |
FirLast@rapharma.com | 2% |
First_L@rapharma.com | 1% |
First-L@rapharma.com | 2% |
First@rapharma.com | 1% |
F.Last@rapharma.com | 1% |
LFirst@rapharma.com | 1% |
First.Last@ucb.com | 95% |
FLast@ucb.com | 3% |
First@ucb.com | 1% |
Last.First@ucb.com | 1% |
Pharmaceutical ManufacturingMassachusetts, United States5001-10000 Employees
On April 2, 2020, Ra Pharmaceuticals, Inc. was acquired by UCB. For more information, please visit www.linkedin.com/company/ucb-pharma.
Ra Pharmaceuticals has raised a total of $150M of funding over 4 rounds. Their latest funding round was raised on Jul 29, 2019 in the amount of $150M.
Ra Pharmaceuticals's revenue is in the range of $100M$1B
Ra Pharmaceuticals has raised a total of $150M of funding over 4 rounds. Their latest funding round was raised on Jul 29, 2019 in the amount of $150M.
Ra Pharmaceuticals's revenue is in the range of $100M$1B